Hao Bo

2.6k citations

65 papers · 1.7k indexed · h-index 23

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation

Papers in ⓘ

Cancer Research 38
- Cancer-related molecular mechanisms research 31
- MicroRNA in disease regulation 7
Molecular Biology 45
- RNA modifications and cancer 17
- Circular RNAs in diseases 13
- RNA Research and Splicing 5
- Epigenetics and DNA Methylation 5

Co-authors: Zhaojian Gong (8 shared papers)Guiyuan Li (6 shared papers)Xiayu Li (5 shared papers)Zhaoyang Zeng (5 shared papers)Wei Xiong (6 shared papers)Ming Zhou (5 shared papers)Wenling Zhang (4 shared papers)Bo Xiang (5 shared papers)
Journals: Journal of Cancer (6 papers)Frontiers in Endocrinology (3 papers)Oncogene (3 papers)Oncotarget (2 papers)Epigenomics (2 papers)
Partner nations: China United States India

In The Last Decade

Hao Bo

64 papers receiving 1.7k citations

Peers

Countries citing papers authored by Hao Bo

Since Specialization

Citations

This map shows the geographic impact of Hao Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Bo more than expected).

Fields of papers citing papers by Hao Bo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Bo. The network helps show where Hao Bo may publish in the future.

Co-authors

The 25 scholars most cited alongside Hao Bo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hao Bo Line = papers co-authored together Hao Bo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma Oncotarget ·Hao Bo, Zhaojian Gong, Wenling Zhang, Xiayu Li, Yong Zeng, Qianjin Liao, Pan Chen, Lei Shi, Yu Lian, Yizhou Jing, Ke Tang, Zheng Li, Yanhong Zhou, Ming Zhou, Bo Xiang, Xiaoling Li, Jianbo Yang, Wei Xiong, Guiyuan Li, Zhaoyang Zeng	2015	188
2	AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis Tumor Biology ·Zhaoyang Zeng, Hao Bo, Zhaojian Gong, Yu Lian, Xiayu Li, Xiaoling Li, Wenling Zhang, Hao Deng, Ming Zhou, Shuping Peng, Guiyuan Li, Wei Xiong	2015	128
3	Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103 Cell Death and Disease ·Baoyu He, Wei‐Ming Li, Yingfen Wu, Fang Wei, Zhaojian Gong, Hao Bo, Yumin Wang, Xiayu Li, Bo Xiang, Can Guo, Qianjin Liao, Pan Chen, Xuyu Zu, Ming Zhou, Jian Ma, Xiaoling Li, Yong Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng	2016	123
4	High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis Journal of Cancer ·Hao Bo, Liqing Fan, Jingjing Li, Zhizhong Liu, Shanshan Zhang, Lei Shi, Can Guo, Xiayu Li, Qianjin Liao, Wenling Zhang, Ming Zhou, Bo Xiang, Xiaoling Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Fang Xiong, Zhaojian Gong	2018	69
5	Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas Science China Life Sciences ·Zhaoyang Zeng, Hongbin Huang, Lili Huang, Mengxi Sun, Qijia Yan, Yali Song, Wei Fang, Hao Bo, Zhaojian Gong, Yong Zeng, Qiao Li, WenLing Zhang, XiaYu Li, Bo Xiang, Xiaoling Li, Yong Li, Wei Xiong, Guiyuan Li	2014	64
6	Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c Oncotarget ·Xiaoying Zhou, Han Chen, Li Zhu, Hao Bo, Weifeng Zhang, Jie Hua, Huiyuan Gu, Wujuan Jin, Guoxin Zhang	2016	62
7	Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis Lipids in Health and Disease ·En-Zhi Jia, Fu-Jun Zhao, Hao Bo, Tie-Bing Zhu, Lian-Sheng Wang, Bo Chen, Ke-Jiang Cao, Jun Huang, Wen-Zhu Ma, Zhi-Jian Yang, Guoxin Zhang	2009	61
8	Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer Journal of Experimental & Clinical Cancer Research ·Zishu Wang, Jin Wang, Yan Yang, Hao Bo, Rui Wang, Yumei Li, Qiong Wu	2013	57
9	Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy Clinical Cancer Research ·Qinghai Zeng, Jianye Liu, Peiguo Cao, Jingjing Li, Xiaoming Liu, Xiaojun Fan, Ling Liu, Yan Cheng, Wei Xiong, Jigang Li, Hao Bo, Yuxing Zhu, Fei Yang, Jun Hu, Ming Zhou, Yanhong Zhou, Qiong Zou, Jianda Zhou, Ke Cao	2017	56
10	Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes Science Advances ·Jianye Liu, Yi Zhang, Qinghai Zeng, Hongliang Zeng, Xiaoming Liu, Pei-Hsun Wu, Hong-Yi Xie, Leye He, Zhi Long, Xiaoyong Lu, Mengqing Xiao, Yuxing Zhu, Hao Bo, Ke Cao	2019	55
11	RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway British Journal of Cancer ·Jian-Ye Liu, Qing-hai Zeng, Peiguo Cao, Dan Xie, Xin Chen, Fei Yang, Le-Ye He, Ying-Bo Dai, Jing-Jing Li, Xiao-Ming Liu, Hong-Liang Zeng, Yi-Xin Zhu, Lian Gong, Yan Cheng, Jian-Da Zhou, Jun Hu, Hao Bo, Zhen-Zhou Xu, Ke Cao	2018	49
12	HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells World Journal of Gastroenterology ·Nana Tang, Hong Zhu, Hongjie Zhang, Weifeng Zhang, Hai-Lin Jin, Lu Wang, Pin Wang, Guijun He, Hao Bo, Ruihua Shi	2014	48
13	SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival Oncogene ·Jia‐Lin Liu, Qing-hai Zeng, Peiguo Cao, D. Xie, Fei Yang, L. Y. He, Yingbo Dai, J. J. Li, X. M. Liu, Hongliang Zeng, Xiaojun Fan, L. Liu, Yuxing Zhu, Lian Gong, Yan Cheng, Jianda Zhou, Jinwen Hu, Hao Bo, Zhen zhou Xu, Ke Cao	2018	45
14	The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo–TAZ pathway Oncogene ·Yuxing Zhu, Dong He, Hao Bo, Zexian Liu, Mengqing Xiao, Liang Xiang, Jianda Zhou, Yan Liu, Xiaoming Liu, Lian Gong, Yanni Ma, Yanhong Zhou, Ming Zhou, Wei Xiong, Fei Yang, Xiaowei Xing, Ruhong Li, Wei Li, Ke Cao	2019	44
15	Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer Oncology Reports ·Hao Bo, Liqing Fan, Zhaojian Gong, Zhizhong Liu, Lei Shi, Can Guo, Xiayu Li, Qianjin Liao, Wenling Zhang, Ming Zhou, Bo Xiang, Xiaoling Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Ke Cao, Shanshan Zhang, Fang Xiong	2019	42
16	Upregulated Expression of Long Non-Coding RNA, LINC00460, Suppresses Proliferation of Colorectal Cancer. Journal of Cancer ·Xin Wang, Fongming Mo, Hao Bo, Lei Xiao, Guan-Yang Chen, Pengwei Zeng, Yanning Huang, Zhuo Lei, Weijie Yuan, Zihua Chen	2018	41
17	LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression Oncogene ·Yuxing Zhu, Jingjing Li, Hao Bo, Dong He, Mengqing Xiao, Liang Xiang, Lian Gong, Yi Hu, Yeyu Zhang, Yaxin Cheng, Liping Deng, Rongrong Zhu, Yanni Ma, Ke Cao	2020	37
18	MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis Science Bulletin ·Liang Xiang, Qinghai Zeng, Jianye Liu, Mengqing Xiao, Dong He, Qun Zhang, Dan Xie, Minhua Deng, Yuxing Zhu, Yan Liu, Hao Bo, Xiaoming Liu, Ming Zhou, Wei Xiong, Yanhong Zhou, Jianda Zhou, Xiaohui Li, Ke Cao	2021	31
19	Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer BMC Cancer ·Fujun Zhao, Xiaoyi Chen, Tingting Meng, Hao Bo, Zhihong Zhang, Guoxin Zhang	2012	30
20	Integrated analysis of high-throughput sequencing data reveals the key role of LINC00467 in the invasion and metastasis of testicular germ cell tumors Cell Death Discovery ·Hao Bo, Fang Zhu, Zhizhong Liu, Qi Deng, Guangmin Liu, Ruixue Li, Wenbing Zhu, Yue‐Qiu Tan, Gang Liu, Jing‐Yu Fan, Liqing Fan	2021	25

About Hao Bo

Hao Bo is a scholar working on Cancer Research, Molecular Biology, Reproductive Medicine, Endocrinology and Surgery, having authored 65 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (31 papers), RNA modifications and cancer (17 papers), Circular RNAs in diseases (13 papers), MicroRNA in disease regulation (7 papers), Testicular diseases and treatments (6 papers), RNA Research and Splicing (5 papers), Epigenetics and DNA Methylation (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.2k citations), Oncology (241 citations), Immunology (160 citations) and Reproductive Medicine (60 citations). Hao Bo has collaborated with scholars based in China, United States and India. Frequent co-authors include Zhaojian Gong, Guiyuan Li, Xiayu Li, Zhaoyang Zeng, Wei Xiong, Ming Zhou, Wenling Zhang, Bo Xiang, Ke Cao and Liqing Fan. Their work appears in journals such as Journal of Cancer, Frontiers in Endocrinology, Oncogene, Oncotarget and Epigenomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact